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Abstract. The aim of this study was to develop microspheres from Thai silk fibroin (SF) 
blended with hyaluronic acid (HA) for controlled release application. HA was introduced 
to blend with SF to enhance properties of the microspheres. The SF-based microspheres 
could be prepared by water in oil emulsion and glutaraldehyde crosslinking technique. The 
obtained microspheres contained 71-91% SF and 9-29% HA. The microspheres having 
higher SF content showed more stability and slower degradation rate. Then, to prove the 
potential of SFHA microspheres as carriers for drug delivery, curcumin was absorbed in 
the microspheres. All microspheres released curcumin in a controllable manner, possibly 
due to the hydrophobic interaction between curcumin and crystalline domain of SF. 
Furthermore, it was shown that HA was self-released from the microspheres. The GA-
crosslinked SFHA microspheres that simultaneously and controlled released curcumin and 
HA could be further developed and applied as injectable drug delivery system for 
treatment of diseases e.g. arthritis. 
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1. Introduction 
 
Silk fibroin (SF) is a natural fibrous protein which is derived from domesticated silkworm, Bombyx mori. SF 
is composed of heavy (H) and light (L) chains linked by disulfide bond. A glycoprotein (p25) is also non-
covalently linked to these chains. SF structure (β-sheet of H-chain and amorphous of L-chain) contributes 
to its outstanding mechanical properties which offer an appropriate balance of modulus, strength and 
elongation. Other attractive properties of SF include biocompatibility, minimal inflammatory reaction, and 
slow biodegradation rate. Therefore, SF has recently been widely applied as scaffolding in tissue engineering 
such as vascular tube for flow diverting devices and stents [1-3], SF-composites used in skin, bone and 
cartilage [4-9]. Additionally, SF has been introduced as carriers for drug delivery system. SF and SF-
composited materials exhibit high encapsulation efficiency and controllable release kinetics, especially to 
hydrophobic molecules or drugs due to the hydrophobic interaction with crystalline region of SF [10-13]. 
Hyaluronic acid (HA) is a linear polysaccharide composed of N-acetyl-D-glucosamine and glucoronic 
acid linked by β-1, 3 and β-1, 4 glucosidic linkages. Besides its biodegradability and biocompatibility, the 
remarked properties are viscoelasticity and ability to absorb large quantities of water [14, 15]. Moreover, it 
regulates proliferation, migration, and differentiation of various cells [16, 17]. HA has been extensively used 
for medical applications, including moisturizer to enhance wound healing, or a lubricant in eyes and joints 
of osteoarthritis disease [18, 19]. HA has also been utilized as tissue engineered scaffolds and drug carriers 
[19, 20].  
Curcumin is a substance of curcuminiods which is a polyphenolic compound. It is composed of two 
aromatic rings which have two groups of phenolic linked together by α, β-unsaturated at the position of 
carbonyl groups, making the curcumin highly hydrophobic and water-insoluble. An antioxidant activity of 
curcumin by acting as a scavenger to unstable free radicals is widely reported [21, 22]. Curcumin can relief 
inflammation of the osteoarthritis and rheumatoid diseases by inhibition of reactive oxygen species (ROS) 
formed by activated macrophage [23-27]. Curcumin also shows anticancer activity by anti-angiogenesis and 
decreasing of the electrical potential of mitochondria membrane, resulting in the releasing of cytochrome-c 
and activating of some enzymes involved in cell death [28-30]. In addition, curcumin possesses other 
biological activities, for example, antiviral and antibacterial [21, 22, 31]. However, the high hydrophobicity, 
low stability, poor systemic bioavailability and rapid metabolism limit its therapeutic potential. Therefore, 
various curcumin delivery systems such as micro/nano particles, micelles, liposomes and scaffolds have 
been developed to enhance its bioavailability and stability [30-37]. Microparticle is an interesting choice of 
carrier in drug delivery system due to its high encapsulation efficiency as a result of large surface area per 
volume, well-defined model for degradation and drug release, controllable size, and can be applied as 
injectable carrier which is minimal invasive.  
In this study, we have attempted to prepare microspheres from Thai silk fibroin (SF) blended with 
hyaluronic acid (HA) using water in oil emulsion and glutaraldehyde crosslinking technique. Based on our 
best knowledge, this is the first report of microspheres prepared from Thai SF protein blended with HA. 
The benefits of HA incorporation would be the enhanced biological activities and the modified degradation 
and drug release rate of the microspheres. We supposed that the developed SF/HA microspheres could 
release the hydrophobic curcumin in a controllable manner, resulting in the effectiveness of its biological 
action. Herein, the blending ratio of SF/HA and crosslinking time were varied to modify morphology, 
degradation rate and stability of SF/HA microspheres. Then, curcumin was loaded into the SF/HA 
microspheres. The entrapment efficiency and in vitro release profile of curcumin from the microspheres 
were evaluated. The SF/HA microspheres with different composition and crosslinking extent were 
introduced as carrier for controlled delivery of curcumin. 
 
2. Materials and Methods 
 
2.1. Materials 
 
The cocoons of B. mori Thai silkworm “Nangnoi Srisaket 1” were a kind gift from Queen Sirikit Sericulture 
Center, Srisaket province, Thailand. Hyaluronic acid (HA, ~ 722 kDa, cosmetic grade) was purchased 
from Namsiang Co. Ltd., Thailand. Lithium bromide (LiBr), glutaraldehyde (GA), glycine, acetone and 
other chemicals used were analytical grade. 
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2.2. Preparation of Regenerated Thai SF Solution and HA Solution 
 
Regenerated Thai SF solution was prepared by subsequent processes of degumming and dissolution 
according to method previously reported [38]. Briefly, the cocoons were degummed by boiling in 0.02 M 
sodium carbonate (Na2CO3) twice to remove sericin and then rinsed thoroughly with deionized (DI) water, 
followed by drying at ambient temperature. To obtain aqueous SF solution, the degummed silk was 
dissolved in 9.3 M LiBr solution. The solution was dialyzed against DI water to remove neutral salts using 
dialysis tube (MWcutoff = 12,000-16,000) until the conductivity of dialyzed water was closed to that of DI 
water. The final concentration of obtained aqueous SF solution was around 6.5-7%wt. 
HA solution was prepared by direct dissolving in DI water and stirring overnight to ensure complete 
solubilization. Prior to the experiments, HA solution was sonicated at 40% amplitude, 30%cycle for 20 min 
to obtain less viscous HA solution. The average molecular weight of sonicated HA determined by intrinsic 
viscosity calculation using Huggins and Kramer equation was 260 kDa [39].  
 
2.3. Preparation of SFHA Microspheres  
 
The SF/HA microspheres were fabricated by water in oil (W/O) emulsion technique. For an aqueous 
phase, 2.5%wt of SF/HA aqueous solutions were prepared at 25°C, pH 6. For an oil phase, soy bean oil 
and Tween 80 were used as an oil and emulsifier, respectively. Then, the SF/HA mixture was added 
dropwise into oil phase (W/O ratio was 1/16) under a constant stirred speed of 300 rpm, 25°C for 20 min. 
Then, the emulsion temperature was decreased to 4°C and continuously stirred for 1 h. The emulsion was 
stabilized by glutaraldehyde (GA) crosslinking. For this step, 3%w/v GA was added dropwise into the 
emulsion. The crosslinking time was varied to 4, 6 and 24 h under darkness condition. The obtained 
microspheres were washed repeatedly with acetone to remove excess oil and immersed in 0.1 M glycine 
aqueous solution to remove unreacted aldehyde groups of GA, followed by rinsing with DI water. The 
GA-crosslinked microspheres were then freeze dried and size-fractionated using sieves (32-85 µm). 
The HA content in obtained SFHA microspheres was determined by modified Elson-Morgan assay [40, 
41]. This was known to measure the amount of N-acetyl-D-glucosamine in HA molecules. Briefly, 10 mg 
microspheres were hydrolyzed with hydrochloric acid (HCl) at 96°C for 14 h, then the pH of hydrolyzed 
solution was adjusted to 7 with 4 N of sodium hydroxide (NaOH). Acetyl acetone solution was prepared by 
mixing 25 ml of 1.25 N sodium carbonate (Na2CO3) with 0.75 ml of acetyl acetone reagent. Then, 2 ml of 
acetyl acetone solution was mixed with 2 ml of hydrolyzed solution and further incubated at 96°C. 
Ehrlich’s regent was prepared by mixing p-dimethylaminobenzaldehyde (DMAB), 6 N HCl and 95%vol 
ethanol together. Then, 2 ml of Ehrlich’s regent was added into the obtained solution. The absorbance of 
the solution was spectrophotometrically measured at the wavelength of 528 nm. The amount of HA was 
determined from a standard curve of N-acetyl-D-glucosamine. The amount of HA in microspheres was 
calculated in relative to the calculated amount of HA in the preparation process as follows: 
 
HA
HA
GlcNAc
GlcNAc
MW
W
MW
W
     (1) 
where GlcNAcW  and HAW  represent the weight of measured N-acetyl-D-glucosamine in microspheres and 
calculated weight of HA in the microsphere preparation, respectively. While GlcNAcMW  and HAMW  
represent the molecular weight of repeating unit of N-acetyl-D-glucosamine and HA, respectively. 
 
2.4. Morphology and Size Analysis of Microspheres 
 
The SF/HA microspheres were immersed in DI water for saturated swelling and dried under critical 
temperature and critical pressure. The morphology of dried SFHA microspheres was observed on a 
scanning electron microscope (SEM, JSM-5410LV, JEOL Ltd, Japan) at the accelerating voltage of 12-15 
kV after sputter-coating with gold. The SF/HA microspheres were randomly cut to observe cross-
sectioned morphology. The average size of SF/HA microspheres (5 mg) was determined by Mastersizer 
2000 (Malvern Instrument Ltd.) (n=3). 
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2.5. Stability Test of SF/HA Microspheres 
 
The stability of SF/HA microspheres was evaluated after immersing microspheres in DI water at 37°C for 
different time intervals. The amounts of HA in the supernatant were determined by modified Elson-
Morgan assay as described earlier. The remained microspheres were freeze dried and weighed. The 
percentage of weight loss was calculated as follows: 
 Weight loss (%) 100


i
fi
W
WW
  (2) 
where Wi and Wf represent dried weight of SF/HA microspheres before and after incubated with DI water, 
respectively (n=3). 
 
2.6. In vitro Biodegradation Test 
 
SF/HA microspheres were incubated in 1 U/ml of Protease XIV solution (pH 7.4) containing 0.01%wt 
sodium azide as anti-bacterial agent at 37°C. The enzymatic solution was changed every 2 days. The 
remained microspheres after incubation were washed with DI water and freeze dried. The dried 
microspheres were weighed and the percentage of remaining weight at different time intervals was 
calculated as follows: 
 Remaining weight (%) 100
b
a
W
W
 (3) 
where bW  and aW represent weight of SF/HA microspheres before and after enzymatic incubation at 
different time intervals, respectively (n=3). 
 
2.7. Evaluation of Entrapment Efficiency and Loading of Curcumin in the SF/HA Microspheres  
 
Curcumin loading in microspheres were carried out by absorption method as follows. Curcumin solution (5 
mg/ml in absolute ethanol) was absorbed on 5 mg of SF/HA microspheres. The absorbed microspheres 
were left at 4°C overnight and air dried for 24 h, then the curcumin loaded SF/HA microspheres were 
obtained. The entrapment efficiency and drug loading were determined by repeatedly washing curcumin 
loaded SF/HA microspheres with dimethyl sulfoxide (DMSO). The absorbance of curcumin eluted in 
DMSO was measured by a spectrophotometer at the wavelength of 430 nm [42, 43]. The entrapment 
efficiency and drug loading were calculated as follows: 
 Entrapment efficiency 100
t
a
M
M
 (4) 
 
 Drug loading (%) 100


sa
a
MM
M
 (5) 
where aM and tM  represent actual and theoretical weight of curcumin in SF/HA microspheres, 
respectively.  sM  represents the weight of SF/HA microspheres (n=3). 
 
2.8. In vitro Release of Curcumin from SF/HA Microspheres 
 
The in vitro release of curcumin was evaluated in enzymatic condition using protease XIV. The known 
amount of curcumin loaded SF/HA microspheres were dispersed in 10 ml phosphate buffer saline (PBS, 
pH 7.4) containing 10%vol fetal bovine serum (FBS) and 1 U/ml of protease XIV and incubated at 37°C. 
At predetermined time intervals, the supernatant was collected and the absorbance of curcumin in releasing 
medium was measured using a spectrophotometer at the wavelength of 430 nm. The fresh releasing 
medium was replaced with the same volume. The concentration of released curcumin was calculated from a 
standard curve of curcumin prepared in phosphate buffer saline (PBS) at various concentrations. The 
percentage of cumulative release of curcumin from SF/HA microspheres was calculated as follows: 
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i
t
i ii
CMC   0  (6) 
 Cumulative release (%) 100
T
i
C
C
 (7) 
where iC , iM  and TC  represent the amounts of released curcumin from SF/HA microspheres at time 
intervals, released curcumin from SF/HA microspheres at time 𝑖 and total amount of curcumin entrapped 
in microspheres (n=3). 
 
2.9. Mathematical Modelling of Curcumin Release 
 
To explain the kinetic and mechanism of curcumin release, the release profile data were fitted into a Power 
law model. The calculation was determined as follows: 
 
nt kt
M
M


 (8) 
where 
M
M t
 represents the fraction of curcumin release at time t, and k, n represent release constant and 
release exponent, respectively. For the power law model (Spherical system), a value of n = 0.43 indicates a 
fickian diffusion mechanism, a value of n = 0.85 indicates a case II transport (relaxation or erosion 
mechanism) and a value of n between 0.43 and 0.85 indicates an anomalous transport [44-46]. 
 
2.10. Statistical Analysis 
 
One way analysis of variance (ANOVA) was performed to compare individual set of data. In all cases, the 
results were considered to be significantly different when p-value < 0.05 (n=3). 
 
3. Results 
 
3.1. HA Content in SF/HA Microspheres 
 
The percentage of HA presented in GA-crosslinked SF/HA microspheres is shown in Fig. 1. The amounts 
of HA in 3 formulations of GA-crosslinked microspheres were about 18-29%, 11-24% and 9-14%, 
respectively. The microspheres were then named based on the actual percentage of HA as follows: 
SF82HA18, SF89HA11, and SF91HA9. Considering the effect of crosslinking time, it was observed that 
the percentage of HA in the GA-crosslinked microspheres seemed to be increased with the increasing 
crosslinking time.  
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Fig. 1. Percentage of HA presented in GA-crosslinked SFHA microspheres crosslinked for 4(  ), 6(  ), 
and 24 h(  )*, **,  , # p < 0.05 when comparing among sample groups at corresponding crosslinking 
time. 
 
3.2. Morphology, Size and Yield of SF/HA Microspheres 
 
Surface morphology, average size, and yield of the dried GA-crosslinked SF/HA microspheres are 
presented in Table 1. The SF/HA microspheres prepared at different weight blending ratios and 
crosslinked for 6 h were spherical with smooth surface. Some aggregated and irregular shaped particles 
were observed on microspheres crosslinked with GA for 4 and 24 h. The cross-sectioned morphology of 
the microspheres revealed a non-porous inner structure (data not shown). Sizes and yields of the 
microspheres after fractionated were around 34-68 µm and 51-67%, respectively. It was noticed that the 
size of the microspheres tended to be bigger for the microspheres containing higher SF content.  
 
Table 1. Morphology, sizes and yields of GA-crosslinked SFHA microspheres prepared at different 
compositions and crosslinked for 4, 6 and 24 h (scale bar = 10 µm).  
 
Crosslinking time 
(h) 
SEM images 
Size of microspheres 
(µm) 
Yield of microspheres 
(%) 
4 
 
SF82HA18 
57.6 ± 3.1 51.8 ± 1.9 
 
SF89HA11 
57.0 ± 2.3 56.5 ± 5.9 
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SF91HA9 
63.2 ± 2.9 56.6 ± 3.2 
6 
 
SF78HA22 
44.9 ± 2.2 63.8 ± 1.3 
 
SF83HA17 
48.7 ± 2.6 67.5 ± 5.5 
 
SF88HA12 
68.0 ± 2.1 57.5 ± 5.6 
24 
 
SF71HA29 
34.4 ± 2.8 56.5 ± 5.9 
 
SF76HA24 
39.8 ± 0.4 56.5 ± 9.3 
 
SF86HA14 
61.4 ± 0.1 58.5 ± 6.1 
 
3.3. Stability of SF/HA Microspheres 
 
The amount and percentage of HA loss from SF/HA microspheres after immersion in DI water are 
demonstrated in Fig. 2. The weight loss of HA per gram of freeze-dried microspheres continuously 
increased with time. The microspheres having higher HA content showed a higher amount of HA loss. The 
percentages of HA loss of all microspheres were around 7-21% after immersion for 144 h. The 
microspheres crosslinked for 4 h revealed higher percentage of HA loss when comparing to corresponding 
microspheres crosslinked for 6 and 24 h. Meanwhile, the amounts of HA detected in supernatant of GA-
crosslinked SF/HA microspheres after immersion in DI water are shown in Fig. 3. The amount of HA in 
the supernatant of microspheres having higher HA content was noticed to be higher than that found in the 
supernatant of microspheres containing lower HA content. It was also observed that the amount of HA in 
supernatant was decreased in the microspheres crosslinked for longer time. The highest amount of HA 
(0.07-0.20 mg/g microspheres) was detected in the supernatant of the microspheres crosslinked for 4 h.  
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Fig. 2. The amount of weight loss of GA-crosslinked SFHA microspheres (left) and the percentage of 
weight loss (right) after immersion in DI water at 37°C for different time intervals.  *p < 0.05 when 
comparing among sample groups at corresponding time. 
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Fig. 3. The amount of HA detected in supernatant after immersed the GA-crosslinked SFHA 
microspheres in DI water at 37°C for different time intervals. *p < 0.05 when comparing among sample 
groups at corresponding time. 
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3.4. In vitro Biodegradation of SF/HA Microspheres 
 
Figure 4 shows the degradation profiles of SF/HA microspheres crosslinked for 6 h after incubated in 1 
U/ml of protease XIV at 37°C for a period of 14 days. The microspheres containing higher SF content 
show slightly higher percentage of weight remaining than those having lower SF content. After 14 days of 
incubation, the weight of microspheres having the highest SF content (SF88HA12) remained 50% while 
those having the lowest SF content (SF78HA22) were only 35% of their original weights. 
 
Fig. 4. Degradation profile of SFHA microspheres crosslinked with GA for 6 h after incubated in PBS 
solution (pH 7.4) containing 10%vol FBS and 1 U/ml of protease XIV at 37°C for different time intervals. 
() SF88HA12; () SF83HA17; () SF78HA22. 
 
3.5. Entrapment and Loading Efficiency of Curcumin in SF/HA Microspheres 
 
Table 2 demonstrates the entrapment and loading efficiency of curcumin in SF/HA microspheres. The 
significant difference in the entrapment and loading efficiencies of curcumin in various formulations of 
SF/HA microspheres was not observed. The entrapment and loading efficiencies of curcumin in all 
microspheres crosslinked with GA for 6 h were approximately 30-33% and 7.1-7.7%, respectively.  
 
Table 2. Entrapment and loading efficiency of curcumin in SFHA microspheres crosslinked with GA for 
6 h. 
 
Sample Entrapment efficiency (%) Loading efficiency (%) 
SF78HA22 33.2 ± 1.1 7.7 ± 0.2 
SF83HA17 32.7 ± 5.3 7.5 ± 1.1 
SF88HA12 30.8 ± 1.7 7.1 ± 0.4 
 
3.6. In vitro Release of Curcumin from SF/HA Microspheres 
 
The profiles of curcumin release from SF/HA microspheres crosslinked with GA for 6 h after incubated in 
PBS solution (pH 7.4) containing 10%v FBS and 1 U/ml of protease XIV are shown in Fig. 5. Initially, the 
curcumin was continuously released to around 80% of original loaded amount. The release of curcumin 
became steady after 36 h (79-84% of curcumin released). The significant difference in curcumin release rate 
among various microspheres was not observed. 
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Fig. 5. In vitro release profile of curcumin from SFHA microspheres crosslinked with GA for 6 h after 
incubated in PBS solution (pH 7.4) containing 10%vol FBS and 1 U/ml of protease XIV at 37°C for 
different time intervals. () SF88HA12; () SF83HA17; () SF78HA22.  
 
Table 3. The constant and exponential values of curcumin released from SFHA microspheres crosslinked 
with GA for 6 h when fit to a power law model. 
 
Sample 
Release 
constant (k) 
Release 
exponent (n) 
Regression 
coefficient (R2) 
SF78HA22 0.16 ± 0.09 0.51 ± 0.08 0.87 
SF83HA17 0.14 ± 0.09 0.55 ± 0.07 0.91 
SF88HA12 0.14 ± 0.07 0.52 ± 0.06 0.85 
 
4. Discussion 
 
In this study, we have developed microspheres from Thai SF and HA to be applied as a carrier of curcumin 
for controlled release applications. The SF/HA microspheres were successfully fabricated by a simple water 
in oil emulsion technique using Tween 80 as an emulsifier. GA was used to crosslink SF/HA microspheres 
during the microdroplet formation. In this case, aldehyde groups of GA would activate hydroxyl groups of 
HA and amino groups of SF to form intermolecular covalent bonds. Then, the GA-crosslinked SF/HA 
microspheres were obtained. The effects of crosslinking time and blending ratios of SF and HA on 
morphology, size, yield, and stability of SF/HA microspheres were elucidated. 
The SEM micrographs revealed a round shape with smooth surface of the microspheres crosslinked 
for 6 h while some aggregated and irregular shaped particles were found in microspheres crosslinked for 4 
and 24 h (Table 1). This might imply that both 4 and 24 h were not appropriate time for the crosslinking 
reaction to occur. The 4 h crosslinking may be too short to achieve the complete crosslinking, resulting in 
unstable microspheres which became aggregated. And there were some high contents of uncrosslinked 
molecules were also leached out during microspheres formation. (the results shown in Figs. 2 and 3) On the 
other hand, the irregular shaped particles were obtained from the microspheres crosslinked for 24 h, 
possibly being a result of mechanical damage from continuous stirring during crosslinking. Then, 6 h 
crosslinking time was suitable for microspheres preparation. The crosslinking time also influence on the 
incorporation of HA in SF/HA microspheres. More HA contents could be stabilized in SF/HA 
microspheres when applying a longer crosslinking time (Fig. 1). Furthermore, the sizes of the obtained 
microspheres after fractionation (34-68 µm) were in the appropriate range for injection through a medical 
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needle which is considered as a minimal invasive treatment [47, 48]. The stability of GA-crosslinked 
SF/HA microspheres depended on both microsphere composition and crosslinking time. The lower 
stability of microspheres having higher HA content (Figs. 2 and 3) was explained by the structural 
characteristic of HA and SF as well as the GA crosslinking ability. HA is an anionic and non-sulfated 
polysaccharide which is hydrophilic and water-soluble. The dissolution of HA could then be easily 
occurred. On the other hand, SF molecules are known to be quite stable and water insoluble due to their 
hydrophobicity and secondary structure. Considering GA crosslinking reaction, GA could crosslink only at 
hydroxyl groups of HA molecules and it required two groups of hydroxyl to complete the crosslinking. 
Moreover, the H-O bond energy in hydroxyl group of HA was higher than H-N bond energy in amino 
group of SF [49]. Therefore, the HA may have less ability to crosslink within the microspheres by GA 
reaction, resulting in its less stability. For further investigation of this study, all SF/HA microspheres 
crosslinked with GA for 6 h were selected because of their controlled morphology without agglomeration, 
appropriate size, yield, and stability. 
We showed that the SF/HA microspheres crosslinked with GA for 6 h were enzymatically degraded by 
Protease XIV [50-52]. Protease XIV specifically cleaves the peptide bonds in SF molecules. The 
degradation profiles confirmed that large amount of SF in SF/HA microspheres was proteolytic degraded 
by protease XIV (Fig. 4). Meanwhile, HA as a water soluble molecule would be either hydrolyzed or 
degraded by enzyme. This explained the faster degradation rate of the microspheres containing higher HA 
content.  
To investigate the potential of SF/HA microspheres as carriers for drug delivery, curcumin was used as 
a model drug. After curcumin was loaded in the microspheres, the entrapment and loading efficiencies were 
evaluated. The significant difference in entrapment and loading efficiencies of curcumin among different 
microspheres were not observed in this study, possibly because all microsphere formulations were SF-based 
(SF 78-88%). The entrapment mechanism of curcumin in our SF-based microspheres might be explained 
by the hydrophobic interaction between the hydrophobic molecules of curcumin and the hydrophobic 
crystalline domain of SF [37, 53]. 
The release study under in vitro enzymatic condition revealed the controllable release profiles of 
curcumin from all microspheres (Fig. 5). The release of curcumin was fast at initial period due to the 
diffusion mechanism. Afterwards, the curcumin would be sustained released along the degradation of 
microspheres. Therefore, there may be two main mechanisms that regulate the release behavior of 
curucmin, diffusion and carrier’s degradation [38, 54]. Comparing among different microsphere 
formulations, the release rate of curcumin was not significantly different. However, it seemed that the 
microspheres having higher SF content showed a slightly slower rate of curcumin release. This may also be 
explained by the hydrophobic interaction between curcumin and SF [10-13, 37, 53]. Ratanavaraporn et al. 
have reported the controlled release of curcumin from different compositions of gelatin/SF microspheres. 
It was found that the presence of SF in microspheres could prolong curcumin release [53]. To explain the 
mechanism of curcumin release from the microspheres, the release data were fit to a mathematical model 
based on regression analysis. The release kinetics and mechanisms of curcumin could be described by a 
power law model. The values of release exponent (n) of curcumin released from all microspheres were 
between 0.43 to 0.85 (Table 3), indicating that the mechanism controlling curcumin release were both 
diffusion and swelling or erosion (anomalous transport). It was supposed that the absorbed curcumin on 
the microspheres’ surface was initially released out by diffusion-controlled mechanism. Thereafter, the 
curcumin attached on the crosslinked microspheres, especially on the hydrophobic domain of SF, was 
released out by microspheres’ dissolution and degradation-controlled mechanism. In addition to the 
curcumin, HA was also continuously self-released from the microspheres due to its dissolution property 
(Fig. 4). Taken together, the GA-crosslinked SF/HA microspheres that simultaneously and sustained 
released curcumin and HA were suggested to be applied as injectable drug delivery system for the treatment 
of diseases e.g. arthritis. However, the further development of SF/HA microspheres is needed to achieve 
the carriers with extended range of sustained release of both curcumin and HA. 
 
5. Conclusion 
 
The SF/HA microspheres were successfully prepared by water-in-oil emulsion and glutaraldehyde 
crosslinking techniques. The obtained microspheres were SF-based. Blending composition of SF and HA 
and crosslinking time influenced on morphology, size, stability, and degradation rate of the microspheres. 
The microspheres containing higher SF content were slightly bigger and more stable while the 
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microspheres crosslinked for 6 h appeared in a spherical shape with smooth surface due to an optimal 
crosslinking time. All microspheres could entrap curcumin as a hydrophobic molecule at around 30-33% 
and released it in a controllable manner, possibly due to the hydrophobic interaction between curcumin and 
hydrophobic domain of SF. These SF/HA microspheres could be further developed to be applied as 
injectable carriers for the treatment of diseases e.g. arthritis. 
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